COVID-19 Resources for National HIV Programs
Tools and resources to support national HIV programs, implementing partners, and community advocates in COVID-19 preparedness
In an effort to share key COVID-19 HIV tools and resources with global stakeholders, CHAI will be updating this webpage on a regular basis and as new resources are shared. If there are any HIV-specific tools and resources that you would like to recommend for inclusion on the New Product Introduction Toolkit, please email HIVToolkit@clintonhealthaccess.org.
Key CHAI Tools and Resources
PEPFAR, Global Fund, and WHO Guidance
Community Resources
-
AfroCAB/CHAI COVID-19 Community Consultation and Webinar Series
-
Rights in the time of COVID-19: Lessons from HIV for an effective, community-led response (UNAIDS)
-
What PLHIV need to know about HIV and COVID-19: Brochure | Infographics (UNAIDS)
-
Maintaining and prioritizing HIV prevention services in the time of COVID-19 (UNAIDS)
-
Lessons from HIV prevention for preventing COVID-19 in low-and middle-income countries (UNAIDS)
-
Resources to support differentiated service delivery during COVID-19 (IAS)
-
Spanish study raises possibility that old-style tenofovir might protect against COVID-19 (aidsmap)
-
London study shows people with HIV not at greater risk of severe COVID-19 illness (aidsmap)
-
April 2020 HIV Treatment News Bulletin (HIV i-Base)
-
CDC Foundation Advanced HIV Disease Series (CDC Foundation/Project ECHO)
-
COVID-19, HIV and TB Webinar - COVID-19 and TPT (Arum Institute)
-
COVID-19, HIV and TB Webinar - Dr. Mary-Ann Davies, Western Cape Department of Health: Preliminary Analysis of Risk Factors for COVID-19 deaths in the province (Arum Institute)
Published Research on the use of ARVs for COVID-19
-
A Trial of LPV/r in Adults Hospitalized with Severe COVID-19 (NEJM, March 2020)
-
Systematic Review of the efficacy and safety of ARVs against SARS, MERS, of COVID-19 (JIAS, March 2020)
-
COVID-19 in Patients with HIV: Clinical Case Series (Lancet, April 2020)
-
Therapeutic Options for COVID-19 Currently Under Investigation (NIH, Ongoing)
-
Darunavir does not prevent SARS CoV-2 infection in HIV patients (Pharmacological Research)
-
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients (Journal of Infectious Disease)
-
No link between HIV status and coronavirus outcomes in large US study (aidsmap)
Global Stakeholder COVID-19 Response Resources
